Panax ginseng: A role in cancer therapy?

Integrative Cancer Therapies

Volumn 2, Issue 1, 2003, Pages 13-33

  Chang, Yuan S ^a   Seo, Eun Kyoung ^b   Gyllenhaal, Charlotte ^c,d   Block, Keith I ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Ewha Womans University   (South Korea)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Block Medical Center   (United States)

Author keywords

Cancer; Ginseng; Panax; Review fatigue

Indexed keywords

GINSENOSIDE;

ANTINEOPLASTIC ACTIVITY; CANCER THERAPY; CHINA; CHRONIC DISEASE; DRUG ACTIVITY; FATIGUE; GINSENG; HERBAL MEDICINE; HYPERGLYCEMIA; IMMUNOMODULATION; JAPAN; KOREA; PRIORITY JOURNAL; REVIEW; STRESS; TRADITIONAL MEDICINE;

FEMALE; HUMANS; MALE; MEDICINE, TRADITIONAL; NEOPLASMS; PANAX; PHYTOTHERAPY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0042320415     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534735403251167     Document Type: Review

References (258)

1. Tao HC. Shen-Nung-Pen-Tsao-Ching. Taipei, Taiwan: Chung-Hwa; 1955.
2. Hu SY. A contribution to our knowledge of ginseng. Am J Chin Med. 1977;5:1-23.
3. Anonymous. Consideration of proposals for amendment of Appendices I and II. Available at: http://www.cites.org. Accessed November 16, 2002.
4. Brekhman II. Zhen-shen (Panax ginseng). Leningrad, Russia: Gosudarst Isdat. et Med. Lit; 1955.
5. Petkov W. Pharmacological studies of the drug P. ginseng C.A. Meyer. Arzneim Forsch. 1959;9:305-311.
6. Veninga L. The Ginseng Book. Santa Cruz, Calif: Ruka; 1973.
7. Heffern R. The Complete Book of Ginseng. Millbrae, Calif: Celestial Arts; 1976.
8. Bae HW. Korean Ginseng. 2nd ed. Seoul, Republic of Korea: Korea Ginseng Research Institute; 1978.
9. Hou JP. The Myth and Truth About Ginseng. Cranbury, NJ: AS Barnes and Co; 1978.
10. Fulder SJ. The Root of Being: Ginseng and the Pharmacology of Harmony. London: Hutchinson; 1980.
11. Oura H, Kumagai A, Shibata J, Takagi K, eds. Yakuyo-Ninjin (Ginseng). Tokyo, Japan: Kyoritsu; 1981.
12. Wang B, Shu T, Tuan W, Men S. Jen-Shen Research. Tien-Chin, People's Republic of China: Tien-Chin Scientific Press; 1985.
13. Farnsworth NR, Bederka, JP, Jr. Ginseng-Fantasy, Fiction or Fact? Tile & Till. 1973;59:30-32.
14. Oh JS. Pharmacology of ginseng. Korean J Ginseng Sci. 1976;1:1-11.
15. Kim H, Nam S, Fukura Y, eds. Korean Ginseng Studies, Chemistry-Pharmacology. Kyunggi-Do, Republic of Korea: Ilhwa; 1977.
16. Thakur RS, Goswami, A. Ginseng: a review. Current Research on Medicinal and Aromatic Plants. 1984;2:93-99.
17. Zhang GD. Progress in the chemical constituents and analytical methods of Panax ginseng. Acta Pharm Sinica. 1980;15:375-384.
18. Owen RT. Ginseng: a pharmacological profile. Drugs of Today. 1981;17:343-351.
19. Tanaka O, Kasai R. Saponins of ginseng and related plants. Prog Chem Org Nat Prod. 1984;46:1-76.
20. Phillipson JD, Anderson LA. Ginseng: quality, safety and efficacy? Pharmaceut J. 1978;232:161-165.
21. Shibata S, Tanaka O, Shoji J, Saito H. Chemistry and pharmacology of Panax. In: Wagner H, Hikino H, Farnsworth NR, eds. Economic and Medicinal Plant Research, Vol. 1. London, UK: Academic Press; 1985:217-284.
22. Shibata S. Pharmacology and chemical study of dammarane-type triterpenoids. In: Barton SD, Ollis WD, eds. Advances in Medicinal Phytochemistry. London, UK: John Libbey & Company Ltd; 1986:151-158.
23. Ng TB, Yeung HW. Scientific basis of the therapeutic effects of ginseng. In: Steiner P, ed. Folk Medicine: The Art and the Science. Washington, DC: American Chemical Society; 1986:139-151.
24. Tanaka O, Kasai R, Morita T. Chemistry of ginseng and related plants: recent advances. Abstr Chin Med. 1986;1:130-152.
25. Chang HM, Yeung HW, Tso WW, Koo A, eds. Advances in Chinese Medicinal Materials Research. Singapore: World Scientific; 1985:453-542.
26. Rashap A, Braly B, Stone J. The Ginseng Research Institute's Indexed Bibliography. Roxbury, NY: Ginseng Research Institute; 1984.
27. Carlson AW. Ginseng: America's botanical drug connection to the Orient. Econ Bot. 1986;40:233-249.
28. Hu SY. The genus Panax (ginseng) in Chinese medicine. Econ Bot. 1976;30:11-28.
29. Wen J. Species diversity, nomenclature, phylogeny, biogeography, and classification of the ginseng genus (Panax L., Araliaceae). In: Punja, ZK, ed. Utilization of Biotechnological, Genetic and Cultural Approaches for North American and Asian Ginseng Improvement. Proceedings of the International Ginseng Workshop. Vancouver, Canada: Simon Fraser University Press; 2001.
30. Yun TK. Brief introduction to Panax ginseng C.A. Meyer. J Korean Med Sci. 2001;16(suppl):S3-5.
31. Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annual Rev Pharmacol. 1969;9:419-430.
32. Halstead BW, Hood LL. Eleutherococcus senticosus, Siberian Ginseng: An Introduction to the Concept of Adaptogenic Medicine. Long Beach, Calif: Oriental Healing Arts Institute; 1984.
33. Farnsworth NR, Kinghorn AD, Soejarto DD, Waller D. Siberian ginseng (Eleutherococcus senticosus): current status as an adaptogen. In: Wagner H, Hikino H, Farnsworth NR, eds. Economic and Medicinal Plant Research. Vol. 1. London, UK: Academic Press; 1985:146-217.
34. Anonymous. Ginseng - what it is and isn't! Ginseng Factsheet. Kamloops, British Columbia, Canada: British Columbia Ministry of Agriculture and Food; 1999.
35. Hsu HY. Treating Cancer With Chinese Herbs. Long Beach, Calif: Oriental Healing Arts Institute; 1982.
36. Kamei T, Kumano H, Iwata K, Nariai Y, Matsumoto T. The effect of a traditional Chinese prescription for a case of lung carcinoma. J Altern Complement Med. 2000;6(6):557-559.
37. Garriques S. On panaquilon, a new vegetable substance. Ann Chem Pharm. 1854;90:231-234.
38. Asahina Y, Taguchi B. The constituents of ginseng. Yakugaku Zasshi. 1906;26:549-553.
39. Kondo H, Tanaka O. Constituents of Korean ginseng III. Yakugaku Zasshi. 1920;40:1027-1031.
40. Kotake M. Glucosides I. Glucoside of Panax ginseng. Nippon Kagaku Zasshi. 1930;51:357-360.
41. Wagner-Jauregg T, Roth M. Panaxol, a new constituent of red ginseng root. Pharm Acta Helv. 1962;37:352-356.
42. Hörhammer L, Wagner H, Lay B. Contents of Panax ginseng root, preliminary report. Pharm Ztg, Ver Apoth Ztg. 1961;106:1307-1312.
43. Elyakov GB, Strigina LI, Uvarova NI, Vaskovaky VB, Dzizenko, AK, Kochetkov NX. Glycosides from ginseng roots. Tetrahedron Lett. 1964;48:3591-3597.
44. Besso H, Kasai R, Saruwatari Y, Fuwa T, Tanaka O. Ginsenoside Ra1 and ginsenoside Ra2, new dammarane-saponins of ginseng roots. Chem Pharm Bull. 1982;30:2380-2385.
45. Matsuura H, Kasai R, Tanaka O, Saruwatari Y, Kunihiro K, Fuwa T. Further studies on dammarane-saponins of ginseng roots. Chem Pharm Bull. 1984;32:1188-1192.
46. Sanada S, Kondo N, Shoji J, Tanaka O, Shibata S. Saponins of ginseng. I. Structures of ginsenosides Ro, Rb1, Rb2, Rc, and Rd. Chem Pharm Bull. 1974;22:421-428.
47. Kasai R, Besso H, Tanaka O, Saruwatari Y, Fuwa T. Saponins of red ginseng. Chem Pharm Bull. 1983;31:2120-2125.
48. Yahara S, Kaji K, Tanaka O. Further study on dammarane-type saponins of roots, leaves, flower buds, and fruits of Panax ginseng. Chem Pharm Bull. 1979;27:88-92.
49. Sanada S, Shoji J. Studies on the saponins of ginseng. III. Structures of ginsenoside-Rb3 and 20-glucoginsenoside-Rf. Chem Pharm Bull. 1978;26:1694-1697.
50. Yahara S, Natsuura K, Kasai R, Tanaka O. Saponins of buds and flowers of Panax ginseng (I). Isolation of ginsenosides Rd, Re, and Rg1. Chem Pharm Bull. 1976;24:3212-3213.
51. Yahara S, Tanaka O, Komori T. Saponins of the leaves of Panax ginseng. Chem Pharm Bull. 1976;24:2204-2208.
52. Sanada S, Kondo N, Shoji J, Tanaka O, Shibata S. Saponins of Ginseng. II. Structures of ginsenoside-Re, -Rf, and -Rg2. Chem Pharm Bull. 1974;22:2407-2412.
53. Iida Y, Tanaka O, Shibata S. Saponins of ginseng: the structure of ginsenoside-Rg1. Tetrahedron Lett. 1968;52:5449-5453.
54. Shoji J. Recent advances in the chemical studies on ginseng. In: Chang HM, Yeung HW, Tso WW, Koo A, eds. Advances in Chinese Medicinal Materials Research. Singapore: World Scientific; 1985.
55. Tanaka O, Kasai R, Morita T. Chemistry of ginseng and related plants: recent advances. Abstr Chin Med. 1986;1:130-152.
56. Kitagawa I, Taniyama T, Hayashi T, Yoshikawa M. Malonylginsenoside Rb1, Rb2, Rc and Rd, four new malonylated dammarane type triterpene oligosaccharides from ginseng radix. Chem Pharm Bull. 1983;31:3353-3356.
57. Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Taniyama T. Chemical studies on crude drug precession. I. On the constituents of Ginseng Radix Rubra(I). Yakugaku Zasshi. 1983;103:612-622.
58. Hall T, Lu, ZZ, Yat PN, et al. An introduction to the Ginseng Evaluation Program. HerbalGram. 2001;52:26-30.
59. Cui JF. Identification and quantification of ginsenosides in various commercial ginseng preparations. Eur J Pharmacol Sciences. 1995;3:77-85.
60. Ma YC, Luo M, Malley L, Doucet M. Distribution and proportion of major ginsenosides and quality control of ginseng products. Chinese Journal of Medicinal Chemistry. 1996;6(1):11-21.
61. Harkey MR, Henderson GL, Gerswhin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr. 2001;73:1101-1106.
62. Hall T, Lu ZZ, Yat PN, et al. Evaluation of consistency of standardized Asian ginseng products in the Ginseng Evaluation Program. HerbalGram. 2001;52:31-45.
63. Fahim MS, Fahim Z, Harman JM, et al. Effect of Panax ginseng on testosterone level and prostate in male rats. Arch Androl. 1982;8:261-263.
64. Hess FG, Jr, Parent RA, Stevens KR, Cox GE, Becci PJ. Effects of subchronic feeding of ginseng extract G115 in beagle dogs. Food Chem Toxicol. 1983;21:95-97.
65. Anonymous. Ginseng: the root of the problem. Emergency Medicine. 1980;12:124-126.
66. Anonymous. Ginseng. Medical Letter. 1980;22:72.
67. Hong SP, Yim MH, Joo HK. The effect of Korean ginseng on alloxan diabetes. Korean J Pharmacog. 1976;7:1111-1114.
68. Lee KD, Huemer RP. Antitumoral activity of Panax ginseng extracts. Jap J Pharmacol. 1971;21:299-302.
69. Soldati F. Toxicological studies on ginseng. Abstr 4th Inst Ginseng Symp, Daejon, South Korea, 17-21 Sept 1984. Daejon, South Korea; 1984:Abstr.-56.
70. Kim YC, Han DS, Cho HS, Ahn SM, Huh H, Koo HJ. Polyamine constituents of Korean white ginseng and fresh ginseng root. Saengyak Hakhoechi. 1983;14:39-43.
71. Woo LK. Effect of ginseng saponin on the skin. Ann Rept Nat Prod Res Inst Seoul Nat Univ. 1976;15:135-137.
72. Kim ND, Woo LK. Effect of ginseng saponin on the skin. Korean J Pharmacog. 1976;7:119-121.
73. Sun XB, Matsumoto T, Yamada H. Purification of immune complexes clearance enhancing polysaccharide from the leaves of Panax ginseng, and its biological activities. Phytomedicine. 1994;1:225-231.
74. Hess FG, Jr, Parent RA, Cox GE, Stevens KR, Becci PJ. Reproduction study in rats of ginseng extract G115. Food Chem Toxicol. 1982;20:189-192.
75. Yuan W, Wo X, Han Y, Shang X, Zhang L. Effects of extracts of ginseng and saponins of ginseng in insulin shock and serum glucose. Shenyang Yaokxeuyan Xuebao. 1985;2:207-211.
76. Kim KJ, Kim HS. Effects of Panax ginseng on the side effects of anticancer agent. Chungman Uidae Chapchi. 1982;9(suppl 2):157-194.
77. Fulder SJ. The growth of cultured human fibroblasts treated with hydrocortisone and extracts of the medicinal plant Panax ginseng. Exp Geront. 1977;12:125-131.
78. Morimoto I, Watanabe F, Osawa T, Okitsu T, Kada T. Mutagenicity screening of crude drugs with Bacillus subtilis recassay and Salmonella/microsome reversion assay. Mutat Res. 1982;97:81-102.
79. Lee IP, Matijasevic Z. Safety evaluation of P. ginseng C.A. Meyer. In: Abstracts of the 4th International Ginseng Symposium, Daejon, South Korea, September 12-17, 1984. Seoul: Korea Ginseng Research Institute; 1984:44.
80. Park JK, Jin SH. The toxicological parameter assessment in experimental animals for various dosages of polyacetylene compounds. Korean J Ginseng Sci. 1989;13:49-55.
81. Siegel RK. Ginseng abuse syndrome - problems with the panacea. JAMA. 1979;241:1614-1615.
82. Siegel RK. Ginseng users in the United States: clinical studies of two populations. Abstr Third Int Ginseng Symp, Seoul, Korea, 8-10 Sept 1980. Seoul: Korea Ginseng Research Insttitute; 1980:13.
83. Anonymous. The ginseng abuse syndrome. Medical Herbalism. 1990;2(3):1,4.
84. Anonymous. Case study: ginseng abuse syndrome. Medical Herbalism. 1990;2(3):5.
85. Tierra M. Indications and contraindications for ginseng and other "chi tonics." Medical Herbalism. 1990;2(3):1,4.
86. Sonneborn U, Hansel R. Panax ginseng. In: De Smet PGAM, Keller K, Hansel R, Chandler RF, eds. Adverse Effects of Herbal Drugs. Vol 2. Berlin, Germany: Springer-Verlag; 1992:179-192.
87. Vazquez I, Aguera-Ortiz LF. Herbal products and serious side effects: a case of ginseng-induced manic episode. Acta Psychiatr Scand. 2002;105(1):76-77.
88. Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case. J Clin Psychopharmacol. 1995;15:447-448.
89. Caron MF, Hotsko AL, Robertson S, Mandybur L, Kluger J, White CM. Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother. 2002;36(5):758-763.
90. Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002;25(5):323-344.
91. Dega H, Laporte JL, Frances C, Herson S, Chosidow O. Ginseng as a cause for Stevens-Johnson syndrome? Lancet. 1996;347:1344.
92. Becker BN, Greene J, Evanson J, Chidsey G, Stone WJ. Ginseng-induced diuretic resistance. JAMA. 1996;276:606-607.
93. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Amer J Health Syst Pharm. 1997;54:692-693.
94. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61(15): 2163-2175.
95. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger ginkgo or ginseng: nature of the evidence. Ann Pharmacother. 2000;34(12):1478-1482.
96. Chang TK, Chen J, Bennetton SA. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1. Drug Metab Dispos. 2002;30(4):378-384.
97. Gurley BJ, Gardner SF, Hubbard MA, et al. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther. 2002;72:276-287.
98. Block KI, Gyllenhaal, C. Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug-metabolizing enzymes. Integrative Cancer Therapies. 1(1):83-89.
99. Brekhman II, Dardymov IV. Pharmacological investigation of glycosides from ginseng and eleutherococcus. Lloydia. 1969;32:46-51.
100. Petkov W. The mechanism of action of P ginseng. Arzneim Forsch. 1961;11:288-295, 418422.
101. Takagi K. Pharmacological studies on ginseng. In: Kim HJ, Nam SH, Fukura Y, eds. Korean. Ginseng Studies (Chemistry-Pharmacology). Seoul, South Korea: Il Hwa Co, Ltd; 1977:346-357.
102. Takagi K, Saito H, Nabata H. Pharmacological studies of Panax ginseng root: estimation of pharmacological actions of Panax ginseng root. Jap J Pharmacol. 1972;22:245-259.
103. Takagi K, Saito H, Tsuchiya M. Pharmacological studies of Panax ginseng root: pharmacological properties of a crude saponin fraction. Jap J Pharmacol. 1972;22:339-346.
104. Takagi K, Saito H, Tsuchiya M, Effect of Panax ginseng root on spontaneous movement and exercise in mice. Jap J Pharmacol. 1974;24:41-48.
105. Saito H, Morita M, Takagi K. Pharmacological studies of Panax ginseng leaves. Jap J Pharmacol. 1973;23:43-56.
106. Saito H, Yoshida Y, Takagi K. Effect of Panax ginseng root on exhaustive exercise in mice. Jap J Pharmacol. 1974;24:119-127.
107. Lazarev NW. The non-specific resistance of the body and the neoplastic process. In: VII Mezhdunan Protivorakovyi Kongress 7th, 1962. Moscow-Leningrad, Russia: Medgiz; 1963:383-385.
108. Kim EC, Cho HY, Kim JM. Effect of P. ginseng on the central nervous system: effect of P. ginseng on the emotional response in rats. Korean J Pharmacog. 1971;2:23-28.
109. Wood WB, Roh BL, White RP. Cardiovascular actions of P. ginseng in dogs. Jap J Pharmacol. 1964;14:284-294.
110. Lee WC, Chang WS, Lee SK. Histamine-liberating action of ginseng. New Med J. 1960;3:37.
111. Kitagawa H, Iwaki R. Pharmacological studies of P. ginseng. Fol Pharmacol Jap. 1963;57:348-354.
112. Sakai W. Experimental study of ginseng. Toikaishi. 1917;31:1-44.
113. Song WK. The effect of Panax ginseng essential oil and fat oil on the serotonin liberation. Insam Munhun Teukjip. 1967;3:60-69.
114. Suzuki Y, Hikino H. Mechanisms of h hypoglycemic activity of panaxans A and B, glycans of Panax ginseng roots: effects on plasma level, secretion, sensitivity and binding of insulin in mice. Phytother Res. 1989;3:20-24.
115. Ng TB, Yeung HW. Hypoglycemic constituents of Panax ginseng. Gen Pharmacol. 1985;16:549-552.
116. Kimura Y, Okuda H, Arichi S. Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets. J Pharm Pharmacol. 1988;40:838-843.
117. Singh VK, Agarwal SS, Gupta BM. Immunomodulatory activity of Panax ginseng extract. Planta Med. 1984;50:462-464.
118. Matsuda H, Kubo M, Tani T, Kitagawa I, Mizuno M. Pharmacological study of Panax ginseng CA Meyer (IX). Protective effect of red ginseng on infection (2) on phagocytic activity of mouse reticuloendothelial system. Shoyakugaku Zasshi. 1987;41(2): 135-131.
119. Ahn YK, Kim YK, Chung JG, Kim JH, Goo JD. The effect of Korean ginseng on the immunotoxicity of mitomycin C. Yakhak Hoe Chi. 1987;31:355-360.
120. Park HW, Kim SC, Jung NP. The effect of ginseng saponin fractions on humoral immunity of mouse. Korea J Ginseng Sci. 1988;12:63-67.
121. Ohtani K, Mizutani K, Kasai R, et al. Reticuloendothelial system activating polysaccharides from Panax species: P. notoginseng, P. ginseng, and P. japonicus. J Pharmacobio Dyn. 1987;10(3):63.
122. Kim MN, Jung NP. The effect of ginseng saponin fractions on NK activity in mice. Korea J Ginseng Sci. 1989;13:223-228.
123. Ha TY, Lee JH, Kim SH. Effect of Panax ginseng on the graft-versus-host reaction, production of leucocyte migration inhibitory factor and expulsion of adult Trichinella spiralis in mice. J Korea Soc Microbiol. 1986;21:133-143.
124. Song JY, Han SK, Son EH, Pyo SN, Yun YS, Yi SY. Induction of secretory and tumoricidal activities in peritoneal macrophages by ginsan. Int Immunopharmacol. 2002;2(7):857-865.
125. Shin JY, Song JY, Yun YS, Yang HO, Rhee DK, Pyo S. Immunostimulating effect of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol Immunotoxicol. 2002;24(3):469-482.
126. Hasegawa H, Suzuki R, Nagaoka T, Tezuka Y, Kadota S, Saiki I. Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol. Biol Pharm Bull. 2002;25(7):861-866.
127. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardized ginseng extract G115 for potentiating vaccination against common cold and/or influenza syndrome. Drugs Exp Clin Res. 1996;22:65-72.
128. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinaceae and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology. 1997;35:229-235.
129. Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res. 1990;16:537-542.
130. Liang HP, Wang ZG, Tian FQ, Geng B. Effects of Astragalus polysaccharides and ginsenosides of ginseng stems and leaves on lymphocyte membrane fluidity and lipid peroxidation in traumatized mice. Zhongguo Zhongyao Zazhi. 1995;20:558-560.
131. Zhou JZ, Xiao WB, Zhang F. Comparison of protective effects of gypenosides and ginsenosides on left ventricular relaxation during acute myocardial ischemia in rats. Zhonghua Yaoxue Zazhi. 1996;207-210.
132. Zhang DX, Yasuda T, Yu YY, et al. Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation. Free Radical Biol Med. 1996;20:145-150.
133. Mei B, Wang YF, Wu JX, Chen WZ. Protective effects of ginsenosides on oxygen free radical induced damages of cultured vascular endothelial cells in vitro. Yao Hsueh Hsueh. 1994;20:801-808.
134. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol. 1998;23:728-732.
135. Yick PK, Poon MKT, Ip SP, Ko KM. In vivo antioxidant mechanism of "Sheng Mai San," a compound formulation. Pharmaceutical Biol. 1998;36:189-193.
136. Chen X. Cardiovascular effects of ginsenosides and their nitric oxide-mediated antioxidant action. Proceedings of the International Symposium on Natural Antioxidants: Molecular Mechanisms and Health Effects; 1996:179-187.
137. Lee BM, Lee SK, Kim HS. Inhibition of oxidative DNA damage, 8-OhdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng). Cancer Lett. 1998;132:219-227.
138. Kim HS, Lee BM. Protective effects of antioxidant supplementation on plasma lipid peroxidation in smokers. J Toxicol Environ Health A. 2001;24(8):583-598.
139. Liu ZQ, Luo XY, Sun YX, Chen YP, Wang ZC. Can ginsenosides protect human erythrocytes against free radical-induced hemolysis? Biochim Biophys Acta. 2002;1572(1):58-66.
140. Avakian EV, Evonuk E, Jr. Effect of Panax ginseng extract on tissue glycogen and adrenal cholesterol depletion during prolonged exercise. Planta Med. 1979;36:43-48.
141. Bombardelli E, Cristoni A, Lietti A. The effect of acute and chronic ginseng saponins treatment on adrenal function: biochemical and pharmacological aspects. In: Proceedings of the Third International Ginseng Symposium, Seoul, Korea, 1980. Seoul: Korean Ginseng Research Institute; 1980:9-16.
142. Hu CY, Kim C. Influence of ginseng on the adrenal ascorbic acid content and rectal temperature of rats exposed to cold and heat. Katorik Uihakpu Nonmunjip. 1967;12:49-60.
143. Wang LC, Lee TF. Effects of ginseng saponins on cold tolerance in young and elderly rats. Planta Med. 2000;66:144-147.
144. Kim ND, Hahn BH, Lee EB, Kong JY, Kim MH, Jin CB. Studies of ginseng on the antistress effects. Soul Taehakkyo Saengyak Yonguso Opjukjip. 1979;18:80-86.
145. Kita T, Hata T, Kawashima Y, Kaku T, Itoh E. Pharmacological actions of ginseng saponin in stress mice. J Pharm Dyn. 1981;4:381-393.
146. Park DL. Effect of P. ginseng on x-ray irradiation and synergistic study on nitromin. Insam Munhun Teukjip. 1964;2:55-65.
147. Pande S, Dumar M, Kumar A. Evaluation of radiomodifying effects of root extract of Panax ginseng. Phytother Res. 1998;12:13-17.
148. Takeda A, Katoh N, Yonezawa M. Restoration of radiation injury by ginseng. 3. Radioprotective effect of thermostable fraction of ginseng extract on mice, rats and guinea pigs. J Radiat Res. 1982;23:150-167.
149. Yonezawa M, Takeda A, Katoh N. Restoration of radiation injury by ginseng extract. In: Proceedings of the Third International Ginseng Symposium, Seoul, Republic of Korea, 1980. Seoul: Korean Ginseng Research Institute; 1980:17-20.
150. Kim C, Han GS. Radioprotective effects of ginseng proteins. Yakhak Hoeji. 1985;29:246-252.
151. Kim C, Choi JE. Effects of radioprotective ginseng protein on UV-induced sister chromatid exchanges. Arch Pharm Res. 1988;11:93-98.
152. Choi YC. Effect of Panax ginseng on carbon tetrachloride induced liver injury and X-irradiation damage in rats. Soul Uidae Chapchi. 1972;13:1-14.
153. Wang B, Cui J, Liu A. Effect of saponin isolated from stems and leaves of ginseng (SSLG) on experimental liver injury. Acta Pharm Sinica. 1983;18:726-731.
154. Hikino H, Kiso Y, Kinouchi J, Sanada S, Shoji J. Validity of the Oriental medicines. 73 liver-protective drugs. 18 antihepatotoxic actions of ginsenosides from Panax ginseng roots. Planta Med. 1985;62-64.
155. Sugiyama K, Ueda H, Shara Y, Kajima Y, Ichio Y, Yokota M. Protective effect of sodium 1-malate, an active constituent isolated from Angelicae Radix, on cis-diamminedichloroplatinum (II)-induced toxic side effect. Chem Pharm Bull. 1994;42:2565-2568.
156. Jin R, Wan LL, Mitsuichi T, Kodama K, Kurashige S. Immunomodulative effects of Chinese herbs in mice treated with anti-tumor agent cyclophosphamide. Yakugaku Zasshi. 1994;114:533-538.
157. Choi SG, Heo MY. Anticlastogenic effect of petroleum ether extract of Panax ginseng against carcinogen-induced micronuclei in mice. Takhak Hoe Chi. 1992;36:334-340.
158. Shibuya K, Satoh M, Hasegawa T, Naganuma A, Imura N. Protective effect of Chinese medicines on toxic side effects of cisdiamminedichloroplatinum in mice. Yakugaku Zasshi. 1987;107:511-516.
159. Wang BX, Cui JC, Liu AJ. The effect of ginseng on immune responses. In: Chang HM, Yeung HW, Tso WW, Koo A, eds. Advances in Chinese Medicinal Materials Research. Singapore: World Scientific; 1985:519-527.
160. Chang PH. The effect of ginseng (Panax ginseng C.A. Meyer) on organism reactivity. Acta Pharm Sinica. 1966;13:106-111.
161. Hiai S, Sasaki S, Oura H. Effect of ginseng saponin on rat adrenal cyclic AMP. Planta Med. 1979;37:15-19.
162. Chang YS, Noh HI, Kim SI. Effect of ginseng on the adrenal cortex function. J Korean Med Assoc. 1981;24:327-331.
163. Hiai S, Yokoyama H, Oura H, Yano S. Stimulation of pituitary-adrenocortical system by ginseng saponin. Endocrinol Jap. 1979;26:661-667.
164. Jin SH, Kim SC, Jung NP. Effect of ginseng components with pepsinogen secretion regulatory agents on cAMP content in isolated rabbit gastric glands. Korean J Ginseng Sci. 1986;10:151-158.
165. Petkov VD, Hadjiivanova C, Petkov VV, Milanov S, Visheva N, Boyadjieva N. Effects of standardized extract GK501, from Ginkgo biloba L., G115 from Panax ginseng C.A. Meyer, and their combination, Gincosan (PHL-00701), on the brain levels of biogenic monoamines and on the serum content of prolactin, growth hormone and ACTH. Phytother Res. 1993;7:139-145.
166. Lee YJ, Chung E, Lee KY, Lee YH, Huh B, Lee SK. Ginsenoside Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol Cell Endocrinol. 1997;133:135-140.
167. Rüeckert KH. A study that proves the great effectiveness of a special extract made from first class Korean ginseng roots. In: Proceedings of the First International Ginseng Symposium, Seoul, Korea, 1974. Seoul, Republic of Korea: Research Institute, Office of Monopoly; 1974:59-64.
168. Saito H, Bao T. Effect of red ginseng on behavior of stressed mice. In: Proceedings of the Fourth International Ginseng Symposium, Seoul, Korea, 1984. Seoul: Korean Ginseng Research Institute; 1984:97-105.
169. Saito, H. Pharmacological properties of Panax ginseng roots. Taisha. 1973;10:556-563.
170. Kaku T, Miyata T, Uruno T, Sako I, Kinoshita A. Chemicopharmacological studies on saponins of Panax ginseng C A Meyer. II. Pharmacological part. Arzneim Forsch. 1975;25:539-547.
171. Lee SC, Lee SJ, Chung KS, You KH, Kim HS. The central effects of red ginseng total saponin component. Korean J Ginseng Sci. 1995;19:22-26.
172. Matsunaga K, Lu XC, Yasuda H, Ito M, Takiguchi T, Ohizumi Y. Effects of Chinese and Paraguayan medicinal plants on the duration of immobility of mice in the forced swimming test. Nat Med. 1997;51:63-66.
173. Tadano T, Nakagawasai O, Niijima F, Tan-No K, Kisara K. The effects of traditional tonics on fatigue in mice differ from those of the antidepressant imipramine: a pharmacological and behavioral study. Am J Chin Med. 2000;28:97-104.
174. Banerjee U, Izquierdo J. Antistress and antifatigue properties of Panax ginseng comparison with piracetam. Acta Physiol Latinoam. 1982;32:277-285.
175. Martinez B, Staba EJ. The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats. Jap J Pharmacol. 1984;35:79-85.
176. Wang BX, Cui JC, Liu AJ, Wu SK. Studies on the anti-fatigue effect of the saponins of stems and leaves of Panax ginseng (SSLG). J Tradit Chin Med. 1983;3:89-94.
177. Yamasaki K, Murakami C, Ohtani K, et al. Effects of the standardized Panax ginseng extract G115 on the D-glucose transport by Ehrlich ascites tumour cells. Phytother Res. 1993;7:200-202.
178. Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol. 1999;55:567-575.
179. Bahrke MS, Morgan WP. Evaluation of the ergogenic properties of ginseng. Sports Med. 2000;29:113-133.
180. Cardinal BJ, Engels HJ. Ginseng does not enhance psychological well-being in healthy, young adults: results of a double-blind, placebo-controlled, randomized trial. J Am Diet Assoc. 2001;101(6):655-660.
181. Ellis JM, Reddy P. Effects of Panax ginseng on quality of life. Ann Pharmacother. 2002;36(3):375-379.
182. Kennedy DO, Scholeya AB, Wesnes KA. Dose dependent changes in cognitive performance following acute administration of ginseng to healthy young volunteers. Nutr Neurosci. 2001;4(4):295-310.
183. Kennedy DO, Scholey AB, Wesnes WA. Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/ Panax ginseng combination to healthy young volunteers. Nutr Neurosci. 2001;4(5):399-412.
184. Scholey AB, Kennedy DO. Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combinations in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol. 2002;17(1):35-44.
185. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl). 2000;152(4):353-361.
186. Knipschild P. Ginseng: trick or treat? A review of experiments among elderly people with vitality problems. Pharmaceutisch Weekblad. 1988;123:4-11.
187. Gross D, Krieger D, Efrat M, Dayan M. Ginseng extract G115 for the treatment of chronic respiratory disease. Schweiz Zeitschrift Ganzheit Medizin. 1995;1:29-33.
188. Ueki H, Kaibara N, Sakagawa M, Hayashi S. Antitumor activity of plant constituents. I. Yakugaku, Zasshi. 1961;81:1641-1644.
189. Sato A. Studies on anti-tumor activity of crude drugs. III. The effects of decreasing resistance of cancer cell in long-term in vitro screening test with aqueous extracts of some crude drugs. Yakugaku Zasshi. 1990;110:490-497.
190. Hwang WI, Sohn JW. Comparative study on the cytotoxic activities of red ginseng of Korea and China. Korean J Ginseng Sci. 1993;17:196-202.
191. Kim CH, Lee KH, Byun EK. Growth inhibition of red ginseng extracts against tumor cell lines by clonogenic assay. Korean J Ginseng Sci. 1998;22:188-192.
192. Kim CH, Lee MS, Lee KH. Anticancer effect of hydrophobic protein fraction from red ginseng by clonogenic assay. Koryo Insam Hakhoe Chi. 1995;19:27-30.
193. Hwang WI. A study on the antitumor activity of Panax ginseng. Korean J Ginseng Sci. 1993;17:52-60.
194. Seong YH, Shin CS, Kim HS, Baba A. Inhibitory effect of ginseng total saponins on glutamate-induced swelling of cultured astrocytes. Biol Pharm Bull. 1995:1776-1778.
195. Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause. 2002;9(2):145-150.
196. Mironova AI. Influence of extracts of the roots of ginseng and eleutherococcus on the growth of Ehrlich carcinoma. Vopr Onkol. 1963;9(1):22-42.
197. Lee JH, Fang Sk, Ahn BZ. Antineoplastic natural products and their analogues. XI. Cytotoxic activity against L1210 cells of some raw drugs from the Oriental medicine and folklore. Korean J Pharmacog. 1986;17:286-291.
198. Hwang WI. A study on the antitumor activity of Panax ginseng. Korean J Ginseng Sci. 1993;17:52-60.
199. Lazarev NW. The non-specific resistance of the body and the neoplastic process. VII Mezhdunan Protivorakovyi Kongress 7th, 1962. Moscow-Leningrad, Russia: Medgiz; 1963:383-385.
200. Yun YS, Lee SY, Kim BS, Yun TK. Studies on the mechanism for action of the cytotoxic fractions from Korean ginseng roots. II. Effects of ethyl acetate fraction from Korean ginseng roots on the biosynthesis of macromolecules. Hanguk Saenghwa Hakhoe Chi. 1980;13:219-234.
201. Ito T, Hsuan CP, Chang HH. Saponins as neoplasm inhibitors. Patent - Papan Kokai Tokkyo Koho-81 46,817;1981:6 pp.
202. Kim J, Hwang H, Woo I. Cytotoxic activity of polyacetylene of ginseng against Hep G2 (hepatoma) and L929 cells, in vitro. Koryo Taehakkyo Uikwa Taehak Nonmunjip. 1993;30:35-52.
203. Im KS, Chung HY, Park SH, Je NK. Anticancer effect of the hydrolyzed nonogluco-ginsenoside of total saponin from ginseng leaf. Koryo Insam Hakhoe Chi. 1995;19:291-294.
204. Jeon BS, Kim NM, Park CK, Yang JW, Chang KS. Effect of controlled atmosphere storage on the antioxidative and cytotoxic activities of fresh red ginseng. Korean J Ginseng Sci. 1996;20:262-268.
205. Yun TK, Yoon RS, Han IW, et al. A study on anti-carcinogenic effect of long-term oral administration of Korean red ginseng in mice and rats exposed to various chemical carcinogens. In: Abstr 3rd Int Ginseng Symp, Seoul, Korea, 8-10 Sept 1980. Seoul: Korea Ginseng Res Inst; 1980:21-23.
206. Yun TK, Yun YS, Han IW. An experimental study on tumor inhibitory effect of red ginseng in mice and rats exposed to various chemical carcinogens. In: Proceedings of the Third International Ginseng Symposium, Seoul, Republic of Korea, 1980. Seoul, Korea: Ginseng Research Institute; 1980:87-113.
207. Yun YS, Jo JK, Moon HS, Kim YJ, Oh YR, Yun TK. Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethane and benzo(a)pyrene. In: Abstr 4th Inst Ginseng Symp, Daejon, South Korea, 17-21 Sept 1984. Seoul, Korea: Ginseng Research Institute; 1984:Abstr.301984.
208. Ronglin Y, Wei L, Xiu-Zhi H. Inductive differentiation effect of ginsenosides on human acute non-lymphocytic leukemic cells in 58 patients. Chung-Kuo Chung His I Chien Ho Tsa Chin. 1993;13:708-722.
209. Sohn J, Lee Ch, Chung DJ, Park SH, Kim I, Hwang WI. Effect of petroleum ether extract of Panax ginseng roots on proliferation and cell cycle progression of human renal cell carcinoma cells. Exp Mol Med. 1998;30:47-51.
210. Duda RB, Gand SS, Archer SY, Meng S, Hodin RA. American ginseng transcriptionally activates p21 mRNA in breast cancer cell lines. J Korean Med Sci. 2001;16(suppl):S54-S60.
211. Tode T, Kikuchi Y, Hirata J, Imaizumi E, Nagata I. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol. 1993;120:24-26.
212. Kim SI, Kang KS, Kim H, Ahn BZ. Panaxyne, a new cytotoxic polyyne from Panax ginseng root against L1210 cell. Kor J Pharmacogn. 1989;20:71-75.
213. Ahn BZ, Kim SI. Beziehung zwischen Struktur und cytotoxischer Aktivitat von Panaxydol-Analogen gegen L1210 Zellen. Arch. Pharm. (Weinheim). 1988;321:61-63.
214. Oh M, Choi YH, Choi S, et al. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol. 1999;15:869-875.
215. Kim SE, Lee YH, Park JH, Lee SK. Ginsenoside Rs4, a new type of ginseng saponin, concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. Eur J Cancer. 1999;35:507-511.
216. Kim YS, Jin SH, Lee YH, Kim SI, Park JD. Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL or Bax in C6Bu-1 cells. Arch Pharm. Res. 1999;22:448-453.
217. Moon J, Yu SJ, Kim HS, Sohn J. Induction of G(1) cell cycle arrest and p27(KIP1) increase by panaxydol isolated from Panax ginseng. Biochem Pharmacol. 2000;59:1109-1116.
218. Kim JY, Lee KW, Kim SH, et al. Inhibitory effect of tumor cell proliferation and induction of G2/M cell cycle arrest by panaxytriol. Planta Med. 2002;68(2):119-122.
219. Liu Wk, Xu SX, Che CT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 2000;67:1297-1306.
220. Kang KS, Kang BC, Lee BJ, et al. Preventive effect of epicatechin and ginsenoside Rb(2) on the inhibition of gap junctional intercellular communication by TPS and H(2)O(2). Cancer Lett. 2000;152:97-106.
221. Hasegawa H, Uchiyama M. Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med. 1998;64:696-700.
222. Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma K. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside Rb2. Biol Pharm Bull. 1994;17:635-639.
223. Fujimoto J, Sakaguchi H, Aoki I, Toyoki H, Khatun S, Tamaya T. Inhibitory effect of ginsenoside Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol. 2001;22(5):339-341.
224. Tatsuka M, Maeda M, Ota T. Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh2. Jpn J Cancer Res. 2001;92(11):1184-1189.
225. Hwang WI, Son HS, Ji RH, Baik NG. Effects of Panax ginseng and sodium ascorbate (vitamin C) treatment on cancer cell growth I. Synergism of combined Panax ginseng and vitamin C action in vitro. Korean J Ginseng Sci. 1989;13:242-247.
226. Gao R, Jin J, Niu Y. Potentiated effects of total saponins of Panax ginseng on inhibition of leukemic cells by cytotoxic drugs. Zhongguo Zhong Xi Yi Jie he Za Zhi. 1999;19(1):17-19.
227. Chen FD, Wu MC, Wang HE, et al. Sensitization of a tumor, but not normal tissue, to the cytotoxic effect of ionizing radiation using Panax notoginseng extract. Am J Chin Med. 2001;29(34):517-524.
228. Aburada M, Takeda S, Ito E, Nakamura M, Hosoya E. Protective effects of juzentaihoto, dried decoctum of 10 Chinese herbs mixture, upon the adverse effects of mitomycin C in mice. J Pharmacobio Dyn. 1983;6:1000-1004.
229. Ito H, Shimura K. Effects of a blended Chinese medicine, Xiao-Chai-Hu-Tang, on Lewis lung carcinoma growth and inhibition of lung metastasis with special reference to macrophage activation. Jap J Pharmacol. 1986;41:107-114.
230. Kang JK, Lee YJ, No KO, et al. Ginseng intestinal metabolite-I (GIM-I) reduces doxorubicin toxicity in the mouse testis. Reprod Toxicol. 2002;16(3):291-298.
231. Duda RB, Zhong Y, Navas Y, Li MZ, Toy BR, Alavarez JG. American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J Surg Oncol. 1999;72:230-239.
232. Matsunaga H, Katano M, Saita T, Yamamoto H, Mori M. Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol. Cancer Chemother Pharmacol. 1994;33:291-297.
233. Nakata H, Kikuchi Y, Tode T, et al. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Japan J Cancer Res. 1998;89:733-740.
234. Hasegawa H, Sung JH, Matsumiya S, et al. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med. 1995;61:409-413.
235. Arichi S, Hayashi T. Antitumor agent containing specific saponins. German patent, Offen 2,828,851;1980:40.
236. Yoo HY, Kim JP. The effect of ginseng on the postoperative immune function of stage III advanced gastric carcinoma patients. Oegua Hakhoegi. 1990;39:43-50.
237. Mor G. The effect of a combination of biologically active substances (Geriatric Pharmaton) on the well-being of cachectic cancer patients. Adv Diet Nutr. 1985:119-120.
238. Yun TK, Choi SY, Hyo YY. Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng? J Korean Med Sci. 2001;16(suppl):S19-827.
239. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol. 1988;27:359-364.
240. Bespalov VG, Anexandrov VA, Limarenko Y, et al. Chemoprevention of mammary, cervix and nervous system carcinogenesis in animals using cultured Panax ginseng drugs and preliminary clinical trials in patients with precancerous lesions of the esophagus and endometrium. J Korean Med Sci. 2001;16(suppl):S42-S33.
241. Ginseng-HCC Chemopreventive Study Osaka Group. Study on chemoprevention of heptatocellular carcinoma by ginseng: an introduction to the protocol. J Korean Med Sci. 2001;16(suppl):S70-S74.
242. Oka H, Yamamoto S, Kuroki T, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saikoto (TJ-9). Cancer. 1995;76:743-749.
243. Nishii T, Kono S, Abe H, et al. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese men. Japan J Cancer Res. 2001;92:836-840.
244. Strickler HD, Wylie-Rosett J, Rohan T, et al. The relation of type 2 diabetes and cancer. Diabetes Technol Ther. 2001;3:263-274.
245. Lai A, Sarcevic B, Prall OW, Sutherland RL. Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1). J Biol Chem. 2001;276:25823-25833.
246. Muti P, Quattrin T, Grant BJ, et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1361-1368.
247. Tchilian EZ, Zhelezarov IE, Hadjiivanova CI. Effect of ginsenoside Rg1 on insulin binding in mice liver and brain membranes. Phytother Res. 1991;5:46-48.
248. Zhang LH, Xiao PG. Recent advances in studies of antihyperlipaemic and antihyperglycaemic compounds from Chinese traditional and herbal medicines. Phytother Res. 1993;7:217-226.
249. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin dependent diabetic patients. Diabetes Care. 1995;18:1373-1375.
250. Vuksan V, Sievenpiper JL, Koo VY, et al. American ginseng (Panax quinquefolius L.) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med. 2000;160:1009-1013.
251. Vuksan V, Stavro MP, Sievenpiper JL, et al. American ginseng improves glycemia in individuals with normal glucose tolerance: effect of dose and time escalation. J Am Coll Nutr. 2000;19(6):738-744.
252. Kuo SC, Teng CM, Lee JC, Ko FN, Chen SC, Wu TS. Antiplatelet components in Panax ginseng. Planta Med. 1990;56:164-167.
253. Yank XJ, Zhang HW, Liu LJ, et al. The effects of three ginsenosides on blood rheology and erythrocytic membrane fluidity in rats with blood stagnancy. Int J Orient Med. 1995;20:68-71.
254. Lee SR, Park JH, Choi KJ, Kim ND. Inhibitory effects of ginsenoside Rg3 on platelet aggregation and its mechanism of action. Korean J Ginseng Sci. 1997;21:132-140.
255. Eagon CL, Elm MS, Teepe AG, Eagon PK, Medicinal botanicals: estrogenicity in rat uterus and liver. Proc Amer Assn Cancer Res. 1997;38:293.
256. Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem. 2001;49:2472-2479.
257. Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I. Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int J Gynaecol Obstet. 1999;67:169-174.
258. Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res. 1999;19:89-99.